Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polymerase III subunit K pseudogene 1 (POLR3KP1) is classified as a pseudogene. There is no evidence in the biomedical literature or major gene databases (including GeneCards, NCBI Gene, UniProt) that POLR3KP1 encodes a functional protein or has a recognized molecular, biological, or therapeutic role. In contrast, functional POLR3K (RNA polymerase III subunit K/RPC10) is a small subunit of the RNA polymerase III complex, but POLR3KP1 specifically denotes a pseudogene, meaning it is a non-functional genomic locus, typically formed by duplication or retrotransposition events, and does not encode a protein product. Pseudogenes are not considered therapeutic drug targets, and thus POLR3KP1 lacks target attributes such as biological function, druggability, or disease relevance. Note: If you intended to inquire about the active RNA polymerase III subunit K (POLR3K/RPC10), please clarify, as POLR3KP1 refers only to the non-functional pseudogene and not the protein-coding gene or its protein product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase III subunit K pseudogene 1 (POLR3KP1).